Genomatica has developed a substantial collection of intellectual property. As of January 31, 2015, we owned or had licensed rights to 132 issued or allowed patents and 491 pending patent applications in the United States and in various foreign jurisdictions, in addition to our trade secrets and other intellectual property rights. Our intellectual property currently targets processes to produce over 20 intermediate and basic chemicals, including our first target chemical, BDO, our second target, butadiene, and our third set of targets, for nylon intermediates.

Genomatica has significant intellectual property related to intermediate and basic chemicals.